News
Overcoming Drug Resistance, Precision Therapies Among Cancer Conference Talks
Leading cancer researchers from UC San Francisco will present talks on environmental and genetic determinants in cancer development, precision cancer treatment with radiotheranostics, overcoming drug resistance, and other cancer research topics at this year’s annual meeting of the American
“Love Island-Style” Power Couple Might Help Unlock HER2 Cancer
In the world of cancer, researchers devote a lot of time to studying the protein receptors HER2 and HER3, which, when paired together can turn into a toxic power couple. Normally, HER2 and HER3 — which are found on all kinds of human cells — help regulate cell growth and survival, according to
Michael Bishop, Nobel-Winning Cancer Researcher, Has Died at 90
UC San Francisco Chancellor emeritus J. Michael Bishop, MD, a pioneering microbiologist who shared the 1989 Nobel Prize in Physiology or Medicine for discovering that every cell in the body harbors genes that can cause cancer, has died at the age of 90. “Mike Bishop was a titan of science and a
Haven’t Heard of Lynch Syndrome? You’re Not Alone.
When Allen Rush learned he carried the genetic mutation known as Lynch syndrome, he understood what was at stake. Years earlier, his daughter Jacqueline was diagnosed with colorectal cancer at age 20, as a result of Lynch. She died three years later. Rush did not know about Lynch syndrome even
Scientists Create Cancer-Fighting Immune Cells Right in the Body
For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized facility where they’re genetically reprogrammed to fight cancer, then ship them back for infusion
Molecular Garbage on Tumors Makes Easy Target for Antibody Drugs
For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only appeared on the inside of cells, where it sent signals that fueled tumor growth and stayed hidden from the immune system. But now researchers at UC San Francisco have
Drug Discovery, Biomarkers, and more at Prostate Cancer Symposium
In late February, the Feng Symposium on Prostate Cancer Revolutions in San Francisco brought together a community of researchers, clinicians, and innovators committed to accelerating treatments for patients with prostate cancer. The event continued the rich legacy of University of California, San